These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Quinazoline thymidylate synthase inhibitors: methods for assessing the contribution of polyglutamation to their in vitro activity. Jackman AL; Kimbell R; Brown M; Brunton L; Boyle FT Anticancer Drug Des; 1995 Oct; 10(7):555-72. PubMed ID: 7495479 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of potent non-polyglutamatable quinazoline antifolate thymidylate synthase inhibitors. Marsham PR; Wardleworth JM; Boyle FT; Hennequin LF; Kimbell R; Brown M; Jackman AL J Med Chem; 1999 Sep; 42(19):3809-20. PubMed ID: 10508430 [TBL] [Abstract][Full Text] [Related]
13. Quinazoline antifolates inhibiting thymidylate synthase: computer modelling of the N10 substituent. Jones TR; Betteridge RF; Neidle S; Jackman AL; Calvert AH Anticancer Drug Des; 1989 Mar; 3(4):243-8. PubMed ID: 2930626 [TBL] [Abstract][Full Text] [Related]
14. Quinazoline-based thymidylate synthase inhibitors: relationship between structural modifications and polyglutamation. Jackman AL; Kimbell R; Brown M; Brunton L; Bisset GM; Bavetsias V; Marsham P; Hughes LR; Boyle FT Anticancer Drug Des; 1995 Oct; 10(7):573-89. PubMed ID: 7495480 [TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of thymidylate synthase by two series of nonclassical quinazolines. McNamara DJ; Berman EM; Fry DW; Werbel LM J Med Chem; 1990 Jul; 33(7):2045-51. PubMed ID: 2362285 [TBL] [Abstract][Full Text] [Related]
16. Benzoyl ring halogenated classical 2-amino-6-methyl-3,4-dihydro-4-oxo-5-substituted thiobenzoyl-7H-pyrrolo[2,3-d]pyrimidine antifolates as inhibitors of thymidylate synthase and as antitumor agents. Gangjee A; Jain HD; McGuire JJ; Kisliuk RL J Med Chem; 2004 Dec; 47(27):6730-9. PubMed ID: 15615522 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents. Gangjee A; Lin X; Kisliuk RL; McGuire JJ J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780 [TBL] [Abstract][Full Text] [Related]
18. Folate-based inhibitors of thymidylate synthase: synthesis and antitumor activity of gamma-linked sterically hindered dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583). Bavetsias V; Jackman AL; Marriott JH; Kimbell R; Gibson W; Boyle FT; Bisset GM J Med Chem; 1997 May; 40(10):1495-510. PubMed ID: 9154971 [TBL] [Abstract][Full Text] [Related]
19. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo. Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461 [TBL] [Abstract][Full Text] [Related]
20. BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors. Gibbs DD; Theti DS; Wood N; Green M; Raynaud F; Valenti M; Forster MD; Mitchell F; Bavetsias V; Henderson E; Jackman AL Cancer Res; 2005 Dec; 65(24):11721-8. PubMed ID: 16357184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]